The group’s principle activity is to operate outpatient imaging centers and PET/CT fusion centers. The group provides PET applications of PET for brain tumor, breast tumor, lung cancer, melanoma, ovarian cancer, thyroid cancer, and coronary artery disease. The group operates from United States.
